The DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo
Abstract
Development of a cell therapy for diabetes would be greatly aided by a renewable supply of human beta-cells. Here we show that pancreatic endoderm derived from human embryonic stem (hES) cells efficiently generates glucose-responsive endocrine cells after implantation into mice. Upon glucose stimulation of the implanted mice, human insulin and C-peptide are detected in sera at levels similar to those of mice transplanted with approximately 3,000 human islets. Moreover, the insulin-expressing cells generated after engraftment exhibit many properties of functional beta-cells, including expression of critical beta-cell transcription factors, appropriate processing of proinsulin and the presence of mature endocrine secretory granules. Finally, in a test of therapeutic potential, we demonstrate that implantation of hES cell-derived pancreatic endoderm protects against streptozotocin-induced hyperglycemia. Together, these data provide definitive evidence that hES cells are competent to generate glucose-responsive, insulin-secreting cells.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In particular, ViaCyte developed a stem cell-derived pancreatic endoderm cell population known as PEC-01, which they demonstrated to mature over several months in vivo into insulin-producing endocrine cells in rodent models.29–31”
From Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes (2023) · cites this paper as [31]
Citations
Cites
Brissova, M., Fowler, M. J., Nicholson, W. E., Chu, A., Hirshberg, B., Harlan, D. M., & Powers, A. C. (2005) · Journal of Histochemistry & Cytochemistry · doi:10.1369/jhc.5c6684.2005 · Cited by 797
Successful Islet Transplantation
Ryan, E. A., Lakey, J. R. T., Paty, B. W., Imes, S., Korbutt, G. S., Kneteman, N. M., Bigam, D., Rajotte, R. V., & Shapiro, A. M. J. (2002) · Diabetes · doi:10.2337/diabetes.51.7.2148 · Cited by 719
Flagged first, then by citations
Research works printed but not linked: 43
- Lakey, J.R., Mirbolooki, M. & Shapiro, A.M. Current status of clinical islet cell transplantation. Methods Mol. Biol. 333, 47–104 (2006).
- Amit, M. et al. Clonally derived human embryonic stem cell lines maintain pluripotency and proliferative potential for prolonged periods of culture. Dev. Biol. 227, 271–278 (2000). · DOI
- Rosler, E.S. et al. Long-term culture of human embryonic stem cells in feeder-free conditions. Dev. Dyn. 229, 259–274 (2004). · DOI
- D'Amour, K.A. et al. Efficient differentiation of human embryonic stem cells to definitive endoderm. Nat. Biotechnol. 23, 1534–1541 (2005). · DOI · Paper page
- D'Amour, K.A. et al. Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells. Nat. Biotechnol. 24, 1392–1401 (2006). · DOI
- Jiang, J. et al. Generation of insulin-producing islet-like clusters from human embryonic stem cells. Stem Cells 25, 1940–1953 (2007). · DOI
- Tuch, B.E., Osgerby, K.J. & Turtle, J.R. Reversal of diabetes in hyperglycaemic nude mice by human fetal pancreas. Transplant. Proc. 21, 2665–2666 (1989).
- Beattie, G.M., Butler, C. & Hayek, A. Morphology and function of cultured human fetal pancreatic cells transplanted into athymic mice: a longitudinal study. Cell Transplant. 3, 421–425 (1994). · DOI
- Hayek, A. & Beattie, G.M. Experimental transplantation of human fetal and adult pancreatic islets. J. Clin. Endocrinol. Metab. 82, 2471–2475 (1997).
- Castaing, M. et al. Blood glucose normalization upon transplantation of human embryonic pancreas into beta-cell-deficient SCID mice. Diabetologia 44, 2066–2076 (2001). · DOI
- Castaing, M., Duvillie, B., Quemeneur, E., Basmaciogullari, A. & Scharfmann, R. Ex vivo analysis of acinar and endocrine cell development in the human embryonic pancreas. Dev. Dyn. 234, 339–345 (2005). · DOI
- Jensen, J. Gene regulatory factors in pancreatic development. Dev. Dyn. 229, 176–200 (2004). · DOI
- Zorn, A.M. & Wells, J.M. Molecular basis of vertebrate endoderm development. Int. Rev. Cytol. 259, 49–111 (2007). · DOI
- Jorgensen, M.C. et al. An illustrated review of early pancreas development in the mouse. Endocr. Rev. 28, 685–705 (2007). · DOI
- Gaber, A.O. et al. Human islet graft function in NOD-SCID mice predicts clinical response in islet transplant recipients. Transplant. Proc. 36, 1108–1110 (2004). · DOI
- Cabrera, O. et al. The unique cytoarchitecture of human pancreatic islets has implications for islet cell function. Proc. Natl. Acad. Sci. USA 103, 2334–2339 (2006). · DOI · Paper page
- Guz, Y. et al. Expression of murine STF-1, a putative insulin gene transcription factor, in beta cells of pancreas, duodenal epithelium and pancreatic exocrine and endocrine progenitors during ontogeny. Development 121, 11–18 (1995). · DOI
- Collombat, P. et al. Embryonic endocrine pancreas and mature beta cells acquire alpha and PP cell phenotypes upon Arx misexpression. J. Clin. Invest. 117, 961–970 (2007). · DOI
- Olbrot, M., Rud, J., Moss, L.G. & Sharma, A. Identification of beta-cell-specific insulin gene transcription factor RIPE3b1 as mammalian MafA. Proc. Natl. Acad. Sci. USA 99, 6737–6742 (2002). · DOI
- Matsuoka, T.A. et al. Members of the large Maf transcription family regulate insulin gene transcription in islet beta cells. Mol. Cell. Biol. 23, 6049–6062 (2003). · DOI
- Matsuoka, T.A. et al. The MafA transcription factor appears to be responsible for tissue-specific expression of insulin. Proc. Natl. Acad. Sci. USA 101, 2930–2933 (2004). · DOI
- Nishimura, W. et al. A switch from MafB to MafA expression accompanies differentiation to pancreatic beta-cells. Dev. Biol. 293, 526–539 (2006). · DOI
- Artner, I. et al. MafB: an activator of the glucagon gene expressed in developing islet alpha- and beta-cells. Diabetes 55, 297–304 (2006). · DOI
- Zhang, C. et al. MafA is a key regulator of glucose-stimulated insulin secretion. Mol. Cell. Biol. 25, 4969–4976 (2005). · DOI
- Wilson, M.E., Kalamaras, J.A. & German, M.S. Expression pattern of IAPP and prohormone convertase 1/3 reveals a distinctive set of endocrine cells in the embryonic pancreas. Mech. Dev. 115, 171–176 (2002). · DOI
- Klimstra, D.S. in Histology for Pathologists. (ed. S.S. Sternberg) 613–647 (Lippincott-Raven Publishers, Philadelphia; 1997).
- Marzban, L. et al. Impaired NH2-terminal processing of human proislet amyloid polypeptide by the prohormone convertase PC2 leads to amyloid formation and cell death. Diabetes 55, 2192–2201 (2006). · DOI
- Okamoto, H. The role of poly(ADP-ribose) synthetase in the development of insulin-dependent diabetes and islet B-cell regeneration. Biomed. Biochim. Acta 44, 15–20 (1985).
- Eizirik, D.L. et al. Major species differences between humans and rodents in the susceptibility to pancreatic beta-cell injury. Proc. Natl. Acad. Sci. USA 91, 9253–9256 (1994). · DOI
- Hosokawa, M., Dolci, W. & Thorens, B. Differential sensitivity of GLUT1- and GLUT2-expressing beta cells to streptozotocin. Biochem. Biophys. Res. Commun. 289, 1114–1117 (2001). · DOI
- Yang, H. & Wright, J.R., Jr. Human beta cells are exceedingly resistant to streptozotocin in vivo. Endocrinology 143, 2491–2495 (2002). · DOI
- Hering, B.J. et al. Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes. J. Am. Med. Assoc. 293, 830–835 (2005). · DOI
- Zertal-Zidani, S., Bounacer, A. & Scharfmann, R. Regulation of pancreatic endocrine cell differentiation by sulphated proteoglycans. Diabetologia 50, 585–595 (2007). · DOI
- Attali, M. et al. Control of beta-cell differentiation by the pancreatic mesenchyme. Diabetes 56, 1248–1258 (2007). · DOI
- Tulachan, S.S. et al. All-trans retinoic acid induces differentiation of ducts and endocrine cells by mesenchymal/epithelial interactions in embryonic pancreas. Diabetes 52, 76–84 (2003). · DOI
- Kobayashi, H. et al. Retinoid signaling controls mouse pancreatic exocrine lineage selection through epithelial-mesenchymal interactions. Gastroenterology 123, 1331–1340 (2002). · DOI
- Tuch, B.E. & Monk, R.S. Regulation of blood glucose to human levels by human fetal pancreatic xenografts. Transplantation 51, 1156–1160 (1991). · DOI
- Tuch, B.E., Jones, A. & Turtle, J.R. Maturation of the response of human fetal pancreatic explants to glucose. Diabetologia 28, 28–31 (1985). · DOI
- Tuch, B.E. Reversal of diabetes by human fetal pancreas. Optimization of requirements in the hyperglycemic nude mouse. Transplantation 51, 557–562 (1991). · DOI
- Fornoni, A. et al. Inhibition of c-jun N terminal kinase (JNK) improves functional beta cell mass in human islets and leads to AKT and glycogen synthase kinase-3 (GSK-3) phosphorylation. Diabetologia 51, 298–308 (2008). · DOI
- Weitgasser, R., Davalli, A.M. & Weir, G.C. Measurement of glucose concentrations in rats: differences between glucose meter and plasma laboratory results. Diabetologia 42, 256 (1999). · DOI
- Joannides, A. et al. Automated mechanical passaging: a novel and efficient method for human embryonic stem cell expansion. Stem Cells 24, 230–235 (2006). · DOI
- Schrot, R.J., Patel, K.T. & Foulis, P. Evaluation of inaccuracies in the measurement of glycemia in the laboratory, by glucose meters, and through measurement of hemoglobin A1c. Clin Diabetes 25, 43–49 (2007). · DOI
Cited by
Sorted by citations
Items 701–800 of 1,003
β-cell replacement sources for type 1 diabetes: a focus on pancreatic ductal cells
Corritore, E., Lee, Y.-S., Sokal, E. M., & Lysy, P. A. (2016) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018816652059 · Cited by 26
“These cells completed their reprogramming into functional insulin-producing derivatives 3–4 months after transplantation into rodents [D’Amour et al. 2006; Kroon et al. 2008; Rezania et al. 2012].”
BackgroundMethodIslet Cell Transplantion: Update on Current Clinical Trials
Schuetz, C., & Markmann, J. F. (2016) · Current Transplantation Reports · doi:10.1007/s40472-016-0103-z · Cited by 30
Kropp, E., Oleson, B. J., Broniowska, K. A., Bhattacharya, S., Chadwick, A., Diers, A. R., Hu, Q., Sahoo, D., Hogg, N., Boheler, K., et al. (2015) · doi:10.5966/sctm.2014-0163 · Cited by 26
Islet Transplantation at the Dresden Diabetes Center: Five Years’ Experience
Ludwig, B., Reichel, A., Kruppa, A., Ludwig, S., Steffen, A., Weitz, J., & Bornstein, S. (2014) · Hormone and Metabolic Research · doi:10.1055/s-0034-1385876 · Cited by 19
Stem cell treatment for type 1 diabetes
Li, M., & Ikehara, S. (2014) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2014.00009 · Cited by 22
Mouse Muscle As an Ectopic Permissive Site for Human Pancreatic Development
Capito, C., Simon, M., Aïello, V., Clark, A., Aigrain, Y. Y., Ravassard, P., & Scharfmann, R. (2013) · Diabetes · doi:10.2337/db13-0554 · Cited by 23
“These progenitors need to be grafted into mice to differentiate into functional pancreatic endocrine cells (40).”
BackgroundResearch status and prospect of stem cells in the treatment of diabetes mellitus
Liu, X., Wang, Y., Li, Y., & Pei, X. (2013) · Science China Life Sciences · doi:10.1007/s11427-013-4469-1 · Cited by 26
Present and future cell therapies for pancreatic beta cell replenishment
Domínguez‐Bendala, J. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i47.6876 · Cited by 24
Restoring insulin production for type 1 diabetes
Tudurí, E., Bruin, J. E., & Kieffer, T. J. (2012) · Journal of Diabetes · doi:10.1111/j.1753-0407.2012.00196.x · Cited by 27
“1 double-positive pancreatic progenitors, transplantation results in the formation of mature insulin-producing cells in vivo.(44,57) Moreover, following an in vivo maturation period of several months in diabetic mice, hESC-derived pancreatic progenitors produced sufficient levels of meal- and glucose-regulated insulin…”
BackgroundGATA believe it: new essential regulators of pancreas development.
Rodríguez-Seguí, S., Akerman, I., & Ferrer, J. (2012) · Journal of Clinical Investigation · doi:10.1172/jci65751 · Cited by 26
“corneal epithelium secretes several types of mucin that adhere to the corneal surface (4) and form a barrier that both provides a physical shield from invaders and creates an “unstirred” micron-thick fluid layer”
Potential of Pluripotent Stem Cells for Diabetes Therapy
Schroeder, I. S. (2012) · Current Diabetes Reports · doi:10.1007/s11892-012-0292-5 · Cited by 24
Raikwar, S. P., & Zavazava, N. (2010) · Transplantation · doi:10.1097/tp.0b013e3181fdd98b · Cited by 23
Liang, S., Zhao, J., Baker, R. K., Tran, E., Zhan, L., & Kieffer, T. J. (2023) · Cell Reports Methods · doi:10.1016/j.crmeth.2023.100466 · Cited by 27
Pignatelli, C., Campo, F., Neroni, A., Piemonti, L., & Citro, A. (2022) · Transplant International · doi:10.3389/ti.2022.10555 · Cited by 33
Stepwise differentiation of functional pancreatic β cells from human pluripotent stem cells
Jin, W., & Jiang, W. (2022) · Cell Regeneration · doi:10.1186/s13619-022-00125-8 · Cited by 35
“Notably, PDX1-positive/NKX6-1-negative cells are found to differentiate into non-functional polyhormonal cells (Aigha and Abdelalim, 2020), while pancreatic progenitor cells co-expressing PDX1 and NKX6-1 derived from human PSCs could mature into functional β cells in vivo when transplanted into mice (Kroon et al., 200…”
BackgroundInfluentialThakur, G., Lee, H., Jeon, R., Lee, S., & Rho, G. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21072388 · Cited by 31
“Noggin BMP inhibitor Suppresses hepatic lineage differentiation hESCs, hiPSCs [15,18,19,40,59,61,65,66]”
BackgroundHuman stem cell models: lessons for pancreatic development and diseasePreprint
Gaertner, B., Carrano, A. C., & Sander, M. (2019) · Genes & Development · doi:10.1101/gad.331397.119 · Cited by 31
“GENES & DEVELOPMENT 33:1475–1490 Published by Cold Spring Harbor Laboratory Press; ISSN 0890-9369/19; www.genesdev.org 1475 (D’Amour et al. 2006; Kroon et al. 2008).”
BackgroundCurrent advanced therapy cell-based medicinal products for type-1-diabetes treatment
Cañibano-Hernández, A., del Burgo, L. S., Espona‐Noguera, A., Ciriza, J., & Pedraz, J. L. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.03.041 · Cited by 26
Ishikawa, D., Diekmann, U., Fiedler, J., Just, A., Thum, T., Lenzen, S., & Naujok, O. (2017) · Stem Cell Reports · doi:10.1016/j.stemcr.2017.10.011 · Cited by 25
“Pure DE cells were obtained using the specific DE marker CXCR4 (Davenport et al., 2016; Diekmann and Naujok, 2016; Kroon et al., 2008; Naujok et al., 2014).”
MethodDirecting Stem Cell Fate: The Synthetic Natural Product Connection.
Johnson, T. C., & Siegel, D. (2017) · Chemical Reviews · doi:10.1021/acs.chemrev.7b00015 · Cited by 25
Massumi, M., Pourasgari, F., Nalla, A., Batchuluun, B., Nagy, K., Neely, E., Gull, R., Nagy, A., & Wheeler, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0164457 · Cited by 25
“The differentiation of pluripotent stem cells (PSCs) to the Pancreatic Progenitor stage with subsequent kidney capsule transplantation has led to the generation of cells with a more betacell-like phenotype [7, 8].”
BackgroundMethodInfluentialCell therapies for pancreatic beta-cell replenishment
Okere, B., Lucaccioni, L., Dominici, M., & Iughetti, L. (2016) · The Italian Journal of Pediatrics/Italian journal of pediatrics · doi:10.1186/s13052-016-0273-4 · Cited by 25
van de Bunt, M., Lako, M., Barrett, A., Gloyn, A. L., Hansson, M. D., McCarthy, M. I., Beer, N. L., & Honoré, C. (2016) · Islets · doi:10.1080/19382014.2016.1182276 · Cited by 23
REST represses a subset of the pancreatic endocrine differentiation program
Martin, D. W., Kim, Y., Sever, D., Mao, C., Haefiiger, J.-A., & Grapin-Botton, A. (2015) · Developmental Biology · doi:10.1016/j.ydbio.2015.07.002 · Cited by 25
“, 2008) or differentiation of human embryonic stem cells (ESC) to islet cells (Kroon et al., 2008; Pagliuca et al., 2014; Rezania et al., 2014).”
BackgroundBioengineered stem cells as an alternative for islet cell transplantation
Moore, S. J., Gala-López, B., Pepper, A. R., Pawlick, R. L., & Shapiro, A. J. (2015) · World Journal of Transplantation · doi:10.5500/wjt.v5.i1.1 · Cited by 24
Current Status of Islet Encapsulation
Robles, L., Storrs, R., Lamb, M. W., Alexander, M., & Lakey, J. (2014) · Cell Transplantation · doi:10.3727/096368913x670949 · Cited by 25
Induction of tissue-specific stem cells by reprogramming factors, and tissue-specific selection
Noguchi, H., Saitoh, I., Tsugata, T., Kataoka, H., Watanabe, M., & Noguchi, Y. (2014) · Cell Death and Differentiation · doi:10.1038/cdd.2014.132 · Cited by 25
“The stepwise differentiation protocol relies on intermediates thought to be similar to cell populations present in the developing embryo.(21,22) ES cells differentiate into DE in stage 1; the DE cells differentiate into GTE in stage 2; the GTE cells differentiate into PP in stage 3; and PP cells differentiate into IPC…”
MethodConcise Review: Pluripotent Stem Cell-Based Regenerative Applications for Failing β-Cell Function
Holditch, S. J., Terzic, A., & Ikeda, Y. (2014) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0184 · Cited by 23
Differentiation of human labia minora dermis-derived fibroblasts into insulin-producing cells
Kim, B., Yoon, B., Moon, J., Kim, J., Jun, E. K., Lee, J.-H., Kim, J. S., Baik, C. S., Kim, A., Whang, K., et al. (2011) · Experimental and Molecular Medicine · doi:10.3858/emm.2012.44.1.002 · Cited by 25
Inhibitors of Src and Focal Adhesion Kinase Promote Endocrine Specification
Afrikanova, I., Yebra, M., Simpkinson, M., Xu, Y., Hayek, A., & Montgomery, A. M. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.290825 · Cited by 25
Norrman, K., Strömbeck, A., Semb, H., & Ståhlberg, A. (2012) · Methods · doi:10.1016/j.ymeth.2012.03.030 · Cited by 25
Induced Pluripotent Stem Cells: Characteristics and Perspectives
Cantz, T., & Martin, U. (2010) · Springer eBooks · doi:10.1007/10_2010_74 · Cited by 23
“In recent years intense basic science has led to improved protocols to differentiate human ES cells into insulin-producing b-cells [102, 103] but still more insights with respect to the (auto-) immunologic reactions causing the loss of b-cells are desired.”
BackgroundUsing stem cells to produce insulin
Soria, B., Gauthier, B. R., Martı́n, F., Tejedo, J. R., Bedoya, F. J., Rojas, A., & Hmadcha, A. (2015) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.2015.1066330 · Cited by 31
“Hence, to promote pancreatic endoderm specification at the expense of other foregut endoderm lineages, Cyclopamine and Noggin are often used in conjunction with RA treatment during hESC differentiation protocols [7,78,88].”
BackgroundInfluentialDiekmann, U., Lenzen, S., & Naujok, O. (2014) · Stem Cells and Development · doi:10.1089/scd.2014.0143 · Cited by 31
“A number of studies showed as proof of concept the in vitro generation of hepatocyte-like cells [3,4], lung/airway epithelial cells [5], or pancreatic cells [6,7] by directed differentiation of human ESCs (hESCs).”
Kaitsuka, T., Noguchi, H., Shiraki, N., Kubo, T., Wei, F., Hakim, F., Kume, S., & Tomizawa, K. (2013) · Stem Cells Translational Medicine · doi:10.5966/sctm.2013-0075 · Cited by 27
From pancreatic islet formation to beta-cell regeneration
Ben-Othman, N., Courtney, M. L., Vieira, A., Pfeifer, A., Druelle, N., Gjernes, E., Faurite, B., Avolio, F., & Collombat, P. (2013) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.01.013 · Cited by 27
“013 [82] Kroon E, Martinson LA, Kadoya K, Bang AG, Kelly OG, Eliazer S, et al.”
de Peppo, G. M., & Marolt, D. (2012) · Journal of Blood Transfusion · doi:10.1155/2012/317632 · Cited by 23
“Examples of specific lineages derived from hESC using directed differentiation approach include functional motor neurons [68, 69], human cardiovascular progenitors [70], pancreatic endoderm [71], insulin-secreting β-cells [72], hepatocytes [73], and others.”
BackgroundLee, M. Y., Bozkulak, E. C., Schliffke, S., Amos, P. J., Ren, Y.-M., Ge, X., Ehrlich, B., & Qyang, Y. (2011) · Biochemical and Biophysical Research Communications - BBRC · doi:10.1016/j.bbrc.2011.10.140 · Cited by 24
Cell therapy for diabetes: Stem cells, progenitors or beta-cell replication?
Góñez, L. J., & Knight, K. R. (2009) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2009.12.014 · Cited by 20
The Hexosamine Biosynthesis Pathway Is Essential for Pancreatic Beta Cell Development
Filhoulaud, G., Guillemain, G., & Scharfmann, R. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.025288 · Cited by 27
Ma, H.-T., Jeppesen, J. F., & Jaenisch, R. (2020) · Cell Reports Medicine · doi:10.1016/j.xcrm.2020.100097 · Cited by 23
Ai, Z., Niu, B., Duan, K., Si, C.-Y., Wang, S.-L., Xiang, L., Zhu, X., Zhu, Q., Feng, C., Yin, Y., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120015 · Cited by 23
In vivo studies of glucagon secretion by human islets transplanted in mice
Tellez, K., Hang, Y., Gu, X., Chang, C., Stein, R. W., & Kim, S. K. (2020) · Nature Metabolism · doi:10.1038/s42255-020-0213-x · Cited by 28
Pancreatic Progenitors and Organoids as a Prerequisite to Model Pancreatic Diseases and Cancer
Hohwieler, M., Müller, M., Frappart, P., & Heller, S. (2019) · Stem Cells International · doi:10.1155/2019/9301382 · Cited by 27
“In vitro, these processes are recapitulated with FGF signaling and subsequent treatment with retinoic acid with parallel BMP signal inhibition through Noggin or LDN193189 [11, 12, 15, 38, 40].”
BackgroundPellegrini, S., Manenti, F., Chimienti, R., Nano, R., Ottoboni, L., Ruffini, F., Martino, G., Ravassard, P., Piemonti, L., & Sordi, V. (2018) · Cell Transplantation · doi:10.1177/0963689718798564 · Cited by 23
Transplanted neural-like cells improve memory and Alzheimer-like pathology in a rat model.
Hoveizi, E., Mohammadi, T., Moazedi, A., Zamani, N., & Eskandary, A. (2018) · Cytotherapy · doi:10.1016/j.jcyt.2018.03.036 · Cited by 23
Gupta, S., Wesolowska-Andersen, A., Ringgaard, A. K., Jaiswal, H., Song, L.-Y., Hastoy, B., Ingvorsen, C., Taheri-Ghahfarokhi, A., Magnusson, B., Maresca, M., et al. (2018) · Stem Cell Research · doi:10.1016/j.scr.2018.04.010 · Cited by 23
“1 (PDX1) had the competence to differentiate into functional beta cells and other pancreas lineages following transplantation into immunocompromised mice (Russ et al., 2015; Nostro et al., 2015; Kroon et al., 2008; Rezania et al., 2012; Kelly et al., 2011; Rezania et al., 2013).”
BackgroundInfluentialJiang, Z.-Z., Shi, D., Tu, Y.-F., Tian, J.-J., Zhang, W.-J., Xing, B., Wang, J., Liu, S.-H., Lou, J., Gustafsson, J., et al. (2018) · Diabetes · doi:10.2337/db17-0885 · Cited by 23
“Given that HFPPCs are able to ameliorate hyperglycemia in diabetic mice after transplantation (7,39,40), the current findings demonstrate that HIP treatment can further enhance HFPPC differentiation, thereby paving the way to enhance the function of HFPPCs for transplantation and improved treatment of the diabetes.”
BackgroundCRISPR/Cas9 genome editing in human pluripotent stem cells: Harnessing human genetics in a dish
Gonzãlez, F. (2016) · Developmental Dynamics · doi:10.1002/dvdy.24414 · Cited by 22
“…A and BMP4 (Laflamme et al., 2007) or functional b cells, by stepwise differentiation of hESCs toward definitive endoderm and pancreatic progenitor stages using chemical compounds and signaling proteins (D’Amour et al., 2005; Kroon et al., 2008; Pagliuca et al., 2014; Rezania et al., 2014) (Fig.”
BackgroundShroff, G., & Barthakur, J. K. (2015) · Annals of Neurosciences · doi:10.5214/ans.0972.7531.220303 · Cited by 23
Evaluation of islets derived from human fetal pancreatic progenitor cells in diabetes treatment
Zhang, W.-J., Xu, S.-Q., Cai, H.-Q., Men, X.-L., Wang, Z., Lin, H., Chen, L., Jiang, Y.-W., Liu, H., Li, C.-H., et al. (2013) · Stem cell research & therapeutics · doi:10.1186/scrt352 · Cited by 23
“It is known that insulin-producing cells derived from human embryonic stem cells or human pancreatic islet progenitor cells could correct hyperglycemia in diabetic mice [32,33].”
Treatment options for diabetes: Potential role of stem cells
Stanekzai, J., Isenović, E. R., & Mousa, S. A. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.010 · Cited by 24
Naujok, O., & Lenzen, S. (2012) · Stem Cell Reviews and Reports · doi:10.1007/s12015-012-9362-y · Cited by 23
Promises and Challenges of Stem Cell Research for Regenerative Medicine
Power, C. A., & Rasko, J. E. J. (2011) · Annals of Internal Medicine · doi:10.7326/0003-4819-155-10-201111150-00010 · Cited by 25
“For instance, human ES cell– derived pancreatic cells implanted into immunodeficient mice are known to protect them from an induced form of diabetes (34).”
BackgroundDo immunotherapy and ß cell replacement play a synergistic role in the treatment of type 1 diabetes?
Li, D., Warnock, G. L., Tu, H.-J., Ao, Z., He, Z., Lu, H., & Dai, L. (2009) · Life Sciences · doi:10.1016/j.lfs.2009.08.016 · Cited by 19
Sermon, K., Simón, C., Braude, P., Viville, S., Borstlap, J., & Veiga, A. (2009) · Human Reproduction · doi:10.1093/humrep/dep062 · Cited by 23
“Positive advances so far are the differentiation into myocardial cells (Laflamme et al., 2007) and insulinproducing cells (Kroon et al., 2008): both studies could show a positive effect of the transplantation of differentiated cells in laboratory animals.”
BackgroundIn Vitro Differentiation of Human Placenta-derived Adherent Cells into Insulin-producing Cells
Sun, N., & Ji, H. (2009) · Journal of International Medical Research · doi:10.1177/147323000903700215 · Cited by 23
Cozzitorto, C., & Spagnoli, F. M. (2019) · Current topics in developmental biology/Current Topics in Developmental Biology · doi:10.1016/bs.ctdb.2018.12.005 · Cited by 29
“Subsequent studies have improved each step of this differentiation protocol, including the initial fate specification, maturation and proliferation (D'Amour et al., 2006; Kroon et al., 2008; Nostro et al., 2011; Pagliuca et al., 2014; Rezania et al., 2013; Russ et al., 2015).”
BackgroundClinical translation of pluripotent stem cell-based therapies: successes and challenges
Christiansen, J. R., & Kirkeby, A. (2024) · Development · doi:10.1242/dev.202067 · Cited by 26
The progress of pluripotent stem cell-derived pancreatic β-cells regeneration for diabetic therapy
Wang, X., Gao, M., Wang, Y., & Zhang, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.927324 · Cited by 20
“Follow-up studies discovered the capacity of (-)-indolactam V (ILV) to direct the induction of PDX1expressing PPs from DE together with FGF10, probably due to the activation of protein kinase C (PKC) signaling (57).”
BackgroundInfluentialTan, L. S., Chen, J., Lim, L., & Teo, A. (2022) · Cell Proliferation · doi:10.1111/cpr.13232 · Cited by 22
“1 pancreatic progenitors were subsequently published.(4,122,123) In 2014, Pagliuca et al.”
BackgroundPluripotent Stem Cell-Derived Pancreatic Progenitors and β-Like Cells for Type 1 Diabetes Treatment.
Sambathkumar, R., Migliorini, A., & Nostro, M. (2018) · Physiology · doi:10.1152/physiol.00026.2018 · Cited by 22
“Studies in hyperglycemic mice demonstrate that hESC-derived PPs generate endocrine cells able to lower serum glucose levels ~20 wk posttransplant (34, 58, 71), whereas S7 -like cells require less time to normalize glycemia (5– 6 wk) (45, 57).”
BackgroundInfluentialEngineering pancreatic tissues from stem cells towards therapy
Takahashi, Y., Takebe, T., & Taniguchi, H. (2016) · Regenerative Therapy · doi:10.1016/j.reth.2016.01.002 · Cited by 22
“This strategy was successful, showing maturation of the pancreatic endoderm derived from human ES cells in mice [36].”
BackgroundCulture of hESC-derived pancreatic progenitors in alginate-based scaffolds.
Formo, K., Cho, C. H., Vallier, L., & Strand, B. (2015) · Journal of Biomedical Materials Research. Part A · doi:10.1002/jbm.a.35507 · Cited by 22
Nagamoto, Y., Takayama, K., Tashiro, K., Tateno, C., Sakurai, F., Tachibana, M., Kawabata, K., Ikeda, K., Tanaka, Y., & Mizuguchi, H. (2015) · Cell Transplantation · doi:10.3727/096368914x681702 · Cited by 27
Hickey, R., Mao, S. A., Amiot, B. P., Suksanpaisan, L., Miller, A. C., Nace, R. A., Glorioso, J. M., O’Connor, M. K., Peng, K. W., Ikeda, Y., et al. (2014) · Liver Transplantation · doi:10.1002/lt.24057 · Cited by 21
Thyroid hormones promote endocrine differentiation at expenses of exocrine tissue.
Aïello, V., Moreno-Asso, A., Servitja, J., & Martín, M. (2014) · Experimental Cell Research · doi:10.1016/j.yexcr.2014.01.030 · Cited by 22
Rodrigues, G. M. C., Matos, A., Fernandes, T. G., Rodrigues, C. A. V., Peitz, M., Haupt, S., Diogo, M. M., Brüstle, O., & Cabral, J. M. (2013) · Stem Cell Reviews and Reports · doi:10.1007/s12015-013-9482-z · Cited by 22
“Current differentiation protocols are able to derive clinically relevant cell populations, such as dopaminergic neurons [9], cardiomyocytes [10] and insulinproducing cells [11], from hPSCs.”
BackgroundThe required beta cell research for improving treatment of type 2 diabetes
Thorens, B. (2013) · Journal of Internal Medicine · doi:10.1111/joim.12096 · Cited by 23
Finally! A human pancreatic β cell line.
Weir, G., & Bonner-Weir, S. (2011) · Journal of Clinical Investigation · doi:10.1172/jci58899 · Cited by 22
Yamanaka, N., Wong, C. J., Gertsenstein, M., Casper, R., Nagy, A., & Rogers, I. (2009) · PLoS ONE · doi:10.1371/journal.pone.0008489 · Cited by 22
Naujok, O., Francini, F., Picton, S., Bailey, C., Lenzen, S., & Jörns, A. (2009) · Diabetes/Metabolism Research Reviews · doi:10.1002/dmrr.965 · Cited by 22
“It is well known that undifferentiated ES cells reside in differentiation cultures and can form teratomas or teratocarcinomas after implantation even if efficient in vitro differentiation protocols have been used [32].”
BackgroundMethodToward a renewable source of pancreatic β-cells
Ricordi, C., & Edlund, H. (2008) · Nature Biotechnology · doi:10.1038/nbt0408-397 · Cited by 22
Furth, M. E., & Atala, A. (2013) · Elsevier eBooks · doi:10.1016/b978-0-12-398358-9.00006-9 · Cited by 46
Zeynaloo, E., Stone, L. D., Dikici, E., Ricordi, C., Deo, S. K., Bachas, L. G., Daunert, S., & Lanzoni, G. (2021) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2021.101063 · Cited by 23
Inducible Pluripotent Stem Cells as a Potential Cure for Diabetes
Verhoeff, K. K., Henschke, S., Marfil‐Garza, B. A., Dadheech, N., & Shapiro, A. M. J. (2021) · Cells · doi:10.3390/cells10020278 · Cited by 34
“Patterning of anterior–posterior axis occurs with exposure to KGF/FGF7 and creates the primitive gut tube [29,30,34].”
BackgroundInfluentialLegøy, T. A., Mathisen, A. F., Al-Jaderi, Z., Vethe, H., Bjørlykke, Y., Abadpour, S., Paulo, J. A., Scholz, H., Ræder, H., Ghila, L., et al. (2020) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2020.00109 · Cited by 21
Robert, T., Mesmaeker, I. D., Hulle, F. V., Suenens, K., Stangé, G., Ling, Z., Haller, C., Bouché, N., Keymeulen, B., Kraus, M., et al. (2019) · Stem Cells Translational Medicine · doi:10.1002/sctm.19-0043 · Cited by 21
Senior, P. A., & Pettus, J. (2018) · Diabetic Medicine · doi:10.1111/dme.13846 · Cited by 24
Southard, S. M., Kotipatruni, R. P., & Rust, W. L. (2018) · PLoS ONE · doi:10.1371/journal.pone.0203126 · Cited by 27
Wallet, M. A., Santostefano, K. E., Terada, N., & Brusko, T. M. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00276 · Cited by 23
Talavera-Adame, D., Woolcott, O., Ignatius-Irudayam, J., Arumugaswami, V., Geller, D., & Dafoe, D. (2016) · Diabetologia · doi:10.1007/s00125-016-4078-1 · Cited by 21
“In vitro hPSCs generate endocrine pancreatic precursors more readily than mature beta cells [6, 9].”
BackgroundStem cells to replace or regenerate the diabetic pancreas: Huge potential & existing hurdles
Bhartiya, D. (2016) · The Indian journal of medical research · doi:10.4103/0971-5916.182615 · Cited by 21
Lymphangiogenesis and angiogenesis during human fetal pancreas development
Roost, M., van Iperen, L., Bernardo, A. D. M., Mummery, C., Carlotti, F., de Koning, E. D., & Lopes, S. M. C. D. S. (2014) · Vascular Cell · doi:10.1186/2045-824x-6-22 · Cited by 21
“The maturation of these cells into fully functional β-cells is only augmented after transplantation into (immunocompromised) mice [8-10] and likely depends upon a favorable microenvironment for cell maturation and function.”
Nizzardo, M., Simone, C., Falcone, M., Riboldi, G. M., Comi, G. P., Bresolin, N., & Corti, S. P. (2013) · Cell Transplantation · doi:10.3727/096368912x657477 · Cited by 25
Yanai, A., Laver, C., Joe, A. W., viringipurampeer, I. A., Wang, X., Gregory, C. Y., & Gregory-Evans, K. (2013) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2012.0524 · Cited by 22
iPS Cell Modeling of Cardiometabolic Diseases
Nakamura, K., Hirano, K., & Wu, S. M. (2012) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-012-9413-4 · Cited by 18
“While some features such as calcium handling [23] may become progressively more similar to mature adult cells with prolonged culturing in vitro [24] or in vivo [25], the full manifestation of adult phenotypes has not been demonstrated thus far.”
Tu, S., & Lin, S.-H. (2012) · Clinical Genitourinary Cancer · doi:10.1016/j.clgc.2012.01.002 · Cited by 21
Goodrich, A., Ersek, A., Varain, N. M., Groza, D., Cenariu, M., Thain, D., Almeida-Porada, G., Porada, C., & Zanjani, E. (2010) · Experimental Hematology · doi:10.1016/j.exphem.2010.03.002 · Cited by 21
“Other hESC-derived cell populations characterized for in-vivo beta-cell-like activity thus far have included endoderm cells from 12-day cultures that successfully generated functional endocrine cells in immune-compromised mice upon the transplantation of 5–10 million cells [4].”
A role for islet neogenesis in curing diabetes
Pittenger, G., Taylor-Fishwick, D., & Vinik, A. (2009) · Diabetologia · doi:10.1007/s00125-009-1322-y · Cited by 21
“For example, in a series of studies from a group at Novocell (San Diego, CA, USA), ESCs were first differentiated into pancreatic endoderm, which could subsequently be induced to differentiate into glucose-sensitive insulin-secreting cells capable of protecting mice from streptozotocin-induced diabetes [12, 13].”
BackgroundHinton, A. C., Hunter, S. E., Reyes, G. X., Fogel, G. B., & King, C. C. (2012) · Advances in genetics · doi:10.1016/b978-0-12-394395-8.00001-3 · Cited by 23
Nakamura, A., Wong, Y. F., Venturato, A., Michaut, M., Venkateswaran, S., Santra, M., Gonçalves, C., Larsen, M., Leuschner, M., Kim, Y. H., et al. (2022) · Stem Cell Reports · doi:10.1016/j.stemcr.2022.03.013 · Cited by 20
Pancreas organoid models of development and regeneration
Grapin‐Botton, A., & Kim, Y. H. (2022) · Development · doi:10.1242/dev.201004 · Cited by 22
Krentz, N. A. J., Shea, L. D., Huising, M. O., & Shaw, J. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(21)00170-4 · Cited by 39
Molakandov, K., Berti, D. A., Beck, A., Elhanani, O., Walker, M., Soen, Y., Yavriyants, K., Zimerman, M., Volman, E., Toledo, I., et al. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.635405 · Cited by 20
Hoveizi, E., & Tavakol, S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.27689 · Cited by 20
“Several different cell types including progenitor or various stem cells have been applied to replace or repair defective tissues (Borowiak et al., 2009; Kroon et al., 2008; Maehr et al., 2009).”
BackgroundPeloso, A., Citro, A., Zoro, T., Cobianchi, L., Kahler-Quesada, A., Bianchi, C., Andres, A., Berishvili, E., Piemonti, L., Berney, T., et al. (2018) · Frontiers in Endocrinology · doi:10.3389/fendo.2018.00445 · Cited by 20
Regenerating β cells of the pancreas – potential developments in diabetes treatment
Dong, S., & Wu, H. (2017) · Expert Opinion on Biological Therapy · doi:10.1080/14712598.2018.1402885 · Cited by 22
“However, using similar protocols with some modifications, the hESC-derived pancreatic endoderm cells can continue to differentiate in vivo and become mature, glucose-responsive endocrine cells when implanted in mice [85,86].”
BackgroundMethodNew Insights into Diabetes Cell Therapy
Lysy, P. A., Corritore, E., & Sokal, E. M. (2016) · Current Diabetes Reports · doi:10.1007/s11892-016-0729-3 · Cited by 19
Nagasaki, H., Katsumata, T., Oishi, H., Tai, P.-H., Sekiguchi, Y., Koshida, R., Jung, Y., Kudo, T., & Takahashi, S. (2014) · PLoS ONE · doi:10.1371/journal.pone.0113022 · Cited by 20
“Therefore, this switch from Mafb to Mafa expression in b cells probably has a crucial meaning for functional maturation in both mouse models and in human embryonic stem cell differentiation [7,8].”
Background
Metadata
- Authors
- Kroon, E., Martinson, L. A., Kadoya, K., Bang, A. G., Kelly, O. G., Eliazer, S., Young, H., Richardson, M., Smart, N. G., Cunningham, J., Agulnick, A. D., D'Amour, K. A., Carpenter, M. K., & Baetge, E. E.
- Venue
- Nature Biotechnology
- Published
- 2008-02-20
- Volume
- 26
- Issue
- 4
- Pages
- 443-452
- ISSN
- 0733-222X (ISSN-L)
- 1087-0156
- 1546-1696
- OpenAlex
- W2106219965
- Cited by
- 1,843
- References
- 0
- Citations by year
- 2026: 26 · 2025: 44 · 2024: 46 · 2023: 88 · 2022: 67 · 2021: 81 · 2020: 85 · 2019: 76 · 2018: 87 · 2017: 98 · 2016: 122 · 2015: 116 · 2014: 156 · 2013: 168 · 2012: 154
- FWCI
- 150.73
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Biotechnology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Pluripotent Stem Cells Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Diabetes and associated disorders
- Keywords
- human embryonic stem cells, beta cell differentiation, glucose-dependent insulin secretion, islet transplantation, diabetes cell therapy, C-peptide, proinsulin processing, streptozotocin-induced hyperglycemia
- MeSH terms
- Animals, Cell Differentiation, Cells, Cultured, Endoderm, Glucose, Humans, Insulin, Cell Culture Techniques, Pancreas, Artificial, Tissue Engineering, Cell Proliferation, Insulin-Secreting Cells, Mice, Embryonic Stem Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review